Trade Gilead GILD

Gilead live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Emma Rose 2025 Sep 01, 10:10

WLFI Token Launch: The Trump Family's Latest Crypto Venture

Ava Grace 2025 Sep 01, 07:10

Alibaba Stock Surges on AI Focus Amidst Ecommerce Competition

Ghko B 2025 Aug 31, 16:00

Coca-Cola (KO) Stock Overview: Is Coca-Cola Stock Expected to Go Up?

stocks
Ghko B 2025 Aug 31, 16:00

Cardano price prediction: Where will ADA be in 5 years?

crypto
Frances Wang 2025 Aug 31, 16:00

DJT Stock Forecast 2025: Why Trump Media Stock Is Fluctuating?

stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Latest news

Show more
Ava Grace 2025 Sep 01, 09:20

EU, US Backing Ukraine Security Plan for Post-Conflict Era

Liam James 2025 Sep 01, 09:20

India Defends Russian Oil Imports, Claims Market Stabilization

Emma Rose 2025 Sep 01, 07:20

Indonesia and Thailand Markets Under Pressure: Political Instability Concerns

Sophia Claire 2025 Sep 01, 06:20

Gold & Silver Surge Amid Geopolitical Uncertainty & Fed Policy

Noah Lee 2025 Sep 01, 02:20

Trump's Election Reform Push: ID Laws & Gerrymandering Spark Controversy

Noah Lee 2025 Sep 01, 01:20

Russia-Ukraine Conflict Escalates: Drone Strikes and Retaliation Intensify

Noah Lee 2025 Sep 01, 01:20

Israeli Strike Kills Hamas Leader, Gaza Future Plans Emerge

Ghko B 2025 Aug 31, 16:00

Asia stock market: Hang Seng Index jumps, Alibaba (BABA) stock surges

Stocks Indices

Info

Spread

0.72

Spread (%)

0.6391 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

140174311424

Shares Outstanding

1240809984

Earnings Date (Next)

2013-01-28

Div Yield

2025-09-29

Ex-Dividend Date

2025-09-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.028

EPS

5.04

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Aug 31, 16:00

Forex Pairs for CFD Trading: USD/CHF, USD/CNY, USD/CAD, AUD/USD

Forex CFD Trading
Ghko B 2025 Aug 31, 16:00

Solana (SOL) price update: how to trade Solana CFDs with markets.com?

Crypto
Frances Wang 2025 Aug 28, 16:00

Online CFD Trading Apps: Avatrade, eToro, Plus 500, markets.com

CFD Trading
Trustpilot